Connect with us

Health

Sacubitril/valsartan drug did not significantly reduce cardiovascular death after heart attack – News-Medical.Net

The heart failure drug sacubitril/valsartan did not significantly reduce the rate of heart failure or cardiovascular death following a heart attack compared to…

Published

on

Article feature image

The heart failure drug sacubitril/valsartan did not significantly reduce the rate of heart failure or cardiovascular death following a heart attack compared to ramipril, an angiotensin-converting enzyme(ACE)inhibitor proven effective in improving survival following heart attacks. Findings from the PARADISE-MI trial were presented at the American College of Cardiologys 70thAnnual Scientific Session.
The study is the first large trial to examine whether sacubitril/valsartan can reduce heart failure…

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

Article feature image
Potato nutrients may reduce risk of hypertension – FreshPlaza.com
Article feature image
Are Migraines and PTSD Linked? – Psychiatric Times